SOFA(n = 466) | SIRS(n = 398) | Difference(95% CI) | |
---|---|---|---|
Female sex, n (%) | 195(41.9) | 217(54.5) | 12.6(6.0–19.2) |
Age, median, years (IQR) | 74.1(65–83) | 71.2(56–80) | 4.7(2.6–6.8) |
Charlson Comorbidity Index, n | |||
0 | 109(23.4) | 125(31.4) | 8.0(2.0–14.0) |
1–2 | 232(49.8) | 195(49.0) | 0.8(÷5.9–7.5) |
3+ | 125(26.8) | 78(19.6) | 7.2(1.6–12.8) |
Previously admitted with sepsis, n (%) | 153(32.8) | 110(27.6) | 5.2(÷0.9–11.3) |
Length of stay, median, days (IQR) | 6.7(4.0–10.6) | 4.3(2.7–7.0) | 1.9(1.3–2.4) |
Vital signs on admission, median (IQR) | |||
Severity of disease | |||
Total SOFA score | 3(2–4) | 0(0–1) | – |
Systolic blood pressure, mmHga (IQR) | 122(106–145) | 135(122–150) | 12(9–15) |
≤ 90 mmHg, n(%) | 37(7.9) | 2 (0.5) | 7.4(4.9–10.0) |
Respiratory rate, breaths/min (IQR) | 21(18–26) | 21 (18–25) | 0 |
Heart rate, beats/min (IQR) | 95(81–112) | 102(93–112) | 7(4–10) |
Peripheral oxygen saturation, %(IQR) | 95(93–97) | 96(94–98) | 1(1–2) |
Core temperature, °Cb (IQR) | 37.7(36.8–38.5) | 38.3(37.5–38.8) | 0.5(0.3–0.7) |
Glasgow Coma Scale < 15, n (%) | 122(30.4) | 30(7.5) | 22.9(18.0–27.8) |
Laboratory variables, median (IQR) | |||
C-reactive protein (mg/L) | 94(36–167) | 104(35–174) | 3(÷13–7) |
White blood cell count, (× 109/L) | 12.4(9.0–17.5) | 13.8(10.5–17.3) | 1.2(0.5–2.0) |
Creatinine (μmol/L) | 111(73–168) | 74(61–92) | 32(25–39) |
Bilirubin (μmol/L) | 11(7–17) | 9(6–13) | 2(1–2) |
Platelet count (× 109/L) | 206(144–280) | 256(207–324) | 57(45–70) |
Lactate (mmol/L)c | 1.4(0.9–2.2) | 1.0(0.7–1.7) | 0.3(0.2–0.4) |
Glucose (mmol/L) | 7.3(6.1–8.9) | 6.7(6.0–8.1) | 0.4(0.1–0.6) |
Admission to ICU, n (%) | 73(15.7) | 20(5.0) | 10.7(6.7–14.6) |
Vasopressor therapy, n (%) | 14(3.0) | 3(0.8) | 2.2(0.4–4.0) |
Ventilation therapy, n (%) | 28(6.0) | 7(1.8) | 4.2(1.7–6.7) |
Dialysis treatment, n (%) | 3(0.6) | 1(0.3) | 0.3(÷0.5–1.2) |